secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001641489-23-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics stockholders elect all nine director nominees at 2023 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with >98% of votes cast; broker non-votes 10.7M shares.
- Say-on-pay approved with 64.7M For (98.4% of votes cast); frequency set to every three years.
- Ratification of Ernst & Young as auditor for FY2023 passed with 75.6M For (98.8% of votes cast).
- Say-on-pay frequency vote: 63.0M for 3 years, 2.3M for 1 year; company to hold vote every 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/vtvt-20230606.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer